Phase 1 ICANS Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study

Cytokine Release SyndromeICANS

Institute of Hematology & Blood Diseases Hospital, China18 enrolled1 locationNCT07169487

Completed

Phase 1

Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KER-047 Administered to Healthy Male Volunteers and Postmenopausal Female Volunteers

Fibrodysplasia ossificans progressiva

Keros Therapeutics, Australia Pty Ltd141 enrolled1 locationACTRN12619000319178